FDA Published Draft Guidance on Development of CAR-T Cell Products Post author:PacConAdmin Post published:March 15, 2022 Post category:Drug Industry Daily The FDA has posted draft guidance for sponsors developing CAR-T cell products. Source: Drug Industry Daily You Might Also Like More Keytruda Trial Failures Pile Up Despite Multiple Approvals September 9, 2022 FDA Seeks Industry Feedback on Industry Barriers to Exposure-Response Analyses April 5, 2018 FDA Expands Cross-Contamination Guidance to Cover Non-Penicillin Beta-Lactam Drugs June 26, 2022